NCT07513363 The Role of Urinary RhoA, NGF, and BDNF Levels in Overactive Bladder and Vitamin D Deficiency Status NOT_YET_RECRUITING Phase NA
NCT07463326 The Efficacy of Transcutaneous Tibial Nerve Stimulation in Women With Idiopathic Overactive Bladder Status ENROLLING_BY_INVITATION Phase NA
NCT07429734 Efficacy of Gabapentin Combined With Solifenacin for Non-neurogenic Overactive Bladder in Women Status NOT_YET_RECRUITING Phase PHASE3
NCT07387315 A Randomized, Placebo-controlled Trial of Nitrous Oxide During In-office Bladder Botox Injections Status NOT_YET_RECRUITING Phase PHASE4
NCT07379372 Bladder Overactivity and Post-Botulinum Toxin Telemonitoring Status NOT_YET_RECRUITING Phase NA
NCT07357714 Urinary Function and Multimorbidity Risks: A Longitudinal Study in Beijing Community-Dwelling Elderly Status NOT_YET_RECRUITING Phase N/A
NCT07337252 Risk Factors for Treatment Failure in Women With Detrusor Overactivity Receiving Combined Pharmacotherapy Status COMPLETED Phase N/A
NCT07312955 Solifenacin Plus Tadalafil vs Solifenacin Alone for Overactive Bladder in Females Status COMPLETED Phase NA
NCT07305298 Mirabegron in Patients With Age-Related Macular Degeneration Status NOT_YET_RECRUITING Phase N/A
NCT07209397 Detrusor Nerve Radiofrequency Ablation for Overactive Bladder in Women Status RECRUITING Phase NA
NCT07187466 Behavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson Disease Status NOT_YET_RECRUITING Phase PHASE4
NCT07178314 At-Home Transcutaneous Tibial Nerve Stimulation for Overactive Bladder in Rural Women Status RECRUITING Phase NA
NCT07175805 Pelvic Floor Disorder Symptoms in Women Seeking Weight Loss Therapy Status NOT_YET_RECRUITING Phase N/A
NCT07046156 Treatment of Overactive Bladder With Anticholinergic Agents Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06983470 Predictive Utility and Mechanisms of Sacral Evoked Responses in Sacral Neuromodulation Status RECRUITING Phase NA